Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-10-21 15:35 Tx date 2022-09-21 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
56 - Grant of rights
|
+3,000,000 vol |
3,000,000 | |
Filed 2021-06-06 22:32 Tx date 2021-06-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+125,000 vol |
1,837,500 | |
Filed 2021-06-06 22:31 Tx date 2021-06-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-125,000 vol |
0 | |
Filed 2021-03-04 21:48 Tx date 2021-03-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
1,712,500 | |
Filed 2021-03-04 21:48 Tx date 2021-03-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-125,000 vol |
125,000 | |
Filed 2021-02-12 20:34 Tx date 2021-02-08 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
400,000 | |
Filed 2021-02-12 20:33 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-02-02 23:08 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-612,500 vol |
250,000 | |
Filed 2021-02-02 23:07 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
56 - Grant of rights
|
+612,500 vol |
862,500 | |
Filed 2021-02-02 23:06 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+612,500 vol |
1,562,500 | |
Filed 2021-02-02 23:05 Tx date 2021-01-29 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$105,000
+700,000 vol $0.15 each |
950,000 | |
Filed 2021-02-02 23:04 Tx date 2021-02-02 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,250
+25,000 vol $0.13 each |
1,587,500 | |
Filed 2020-12-22 20:38 Tx date 2020-12-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
250,000 | |
Filed 2020-12-22 20:38 Tx date 2020-12-01 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-125,000 vol |
250,000 | |
Filed 2020-09-22 22:28 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+125,000 vol |
125,000 | |
Filed 2020-09-22 22:28 Tx date 2020-09-16 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-09-22 22:28 Tx date 2020-09-18 |
$MLCL
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
57 - Exercise of rights
|
-125,000 vol |
375,000 | |
Filed 2020-09-16 10:32 Tx date 2020-09-16 |
$
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units (Molecule)
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2020-09-16 10:32 Tx date 2020-09-16 |
$
Molecule Holdings Inc. |
Reingold, David
4 - Director of Issuer
Direct Ownership
|
8% Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
50 |